Ignite Creation Date:
2024-05-06 @ 1:32 PM
Last Modification Date:
2024-10-26 @ 1:15 PM
Study NCT ID:
NCT04050436
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-02
First Post:
2019-08-02
Brief Title:
Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
Sponsor:
Replimune Inc
Organization:
Replimune Inc
Organization Data
Organization:
Replimune Inc
Class:
INDUSTRY
Study ID:
RPL-002-18
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Replimune Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Regeneron Pharmaceuticals | INDUSTRY |